[go: up one dir, main page]

CN1117731A - 具有抑制精神病活性的芳香杂环化合物 - Google Patents

具有抑制精神病活性的芳香杂环化合物 Download PDF

Info

Publication number
CN1117731A
CN1117731A CN94191142A CN94191142A CN1117731A CN 1117731 A CN1117731 A CN 1117731A CN 94191142 A CN94191142 A CN 94191142A CN 94191142 A CN94191142 A CN 94191142A CN 1117731 A CN1117731 A CN 1117731A
Authority
CN
China
Prior art keywords
compound
butyl
piperazinyl
formula
benzisothiazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94191142A
Other languages
English (en)
Chinese (zh)
Inventor
M·H·诺曼
F·纳瓦斯三世
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of CN1117731A publication Critical patent/CN1117731A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN94191142A 1993-02-10 1994-02-10 具有抑制精神病活性的芳香杂环化合物 Pending CN1117731A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9302622.7 1993-02-10
GB939302622A GB9302622D0 (en) 1993-02-10 1993-02-10 Heteroaromatic compounds

Publications (1)

Publication Number Publication Date
CN1117731A true CN1117731A (zh) 1996-02-28

Family

ID=10730183

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94191142A Pending CN1117731A (zh) 1993-02-10 1994-02-10 具有抑制精神病活性的芳香杂环化合物

Country Status (15)

Country Link
EP (1) EP0683778A1 (fr)
JP (1) JPH08506337A (fr)
CN (1) CN1117731A (fr)
AU (1) AU6005194A (fr)
BG (1) BG99839A (fr)
CA (1) CA2155758A1 (fr)
CZ (1) CZ204495A3 (fr)
FI (1) FI953777A0 (fr)
GB (1) GB9302622D0 (fr)
HU (1) HUT73654A (fr)
IL (1) IL108601A0 (fr)
MX (1) MX9401080A (fr)
SK (1) SK99195A3 (fr)
WO (1) WO1994018196A1 (fr)
ZA (1) ZA94891B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
EP0732332B1 (fr) * 1995-03-17 2001-12-19 Aventis Pharmaceuticals Inc. Benzothiénylpipérazines substituées, leur utilisation comme médicaments et procédés pour leur préparation
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
CZ20031434A3 (cs) * 2000-11-14 2003-09-17 Merck Patent Gmbh Použití kombinovaných selektivních dopamin D2 receptorových antagonistů a 5-HT1A receptorových agonistů
CA2438318A1 (fr) * 2001-02-16 2002-08-29 Aventis Pharmaceuticals Inc. Nouveaux derives heterocycliques d'amides et leur utilisation comme ligands du recepteur de la dopamine d3
WO2003009835A2 (fr) 2001-07-26 2003-02-06 Merck Patent Gmbh Nouvelle utilisation de 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane et de ses sels physiologiquement acceptables
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
GB0222909D0 (en) * 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
US20080275028A1 (en) * 2004-07-20 2008-11-06 Giovanni Gaviraghi Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
WO2013014665A1 (fr) * 2011-07-28 2013-01-31 Mapi Pharma Ltd. Composés intermédiaires et procédé pour la préparation de lurasidone et de sels de celle-ci

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
JP2660407B2 (ja) * 1986-09-26 1997-10-08 住友製薬株式会社 新規なイミド誘導体
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives

Also Published As

Publication number Publication date
HUT73654A (en) 1996-09-30
JPH08506337A (ja) 1996-07-09
ZA94891B (en) 1995-08-10
CA2155758A1 (fr) 1994-08-18
WO1994018196A1 (fr) 1994-08-18
HU9501881D0 (en) 1995-08-28
IL108601A0 (en) 1994-05-30
BG99839A (bg) 1996-02-28
SK99195A3 (en) 1995-12-06
GB9302622D0 (en) 1993-03-24
EP0683778A1 (fr) 1995-11-29
AU6005194A (en) 1994-08-29
MX9401080A (es) 1994-08-31
CZ204495A3 (en) 1996-03-13
FI953777A7 (fi) 1995-08-09
FI953777A0 (fi) 1995-08-09

Similar Documents

Publication Publication Date Title
CN1178917C (zh) 作为nk1受体拮抗剂前药的4-苯基-吡啶衍生物的n-氧化物
CN1249051C (zh) 毒蕈碱性激动剂
CN1255403C (zh) 用作磷酸二酯酶抑制剂的β－咔啉衍生物
CN1036920C (zh) 含杂环碳酸衍生物
CN1234358C (zh) 苯并噻唑衍生物
CN1305862C (zh) 作为腺苷受体配体的7－氨基苯并噻唑衍生物
CN1198804C (zh) 酰胺化合物及其用途
CN1117731A (zh) 具有抑制精神病活性的芳香杂环化合物
CN1040755C (zh) 杂环化合物的制备方法
CN1294577A (zh) 钾通道抑制剂
CN1890208A (zh) 类鸦片受体拮抗剂
CN1835944A (zh) 作为ccr－5拮抗剂的喹啉酰胺衍生物
CN1268949A (zh) 稠合噻吩化合物及其医药用途
CN1020900C (zh) 制备新的取代n-(3-羟基-4-哌啶基)苯甲酰胺的方法
CN100338074C (zh) 杂环化合物和以其为有效成分的脑机能改善剂
CN1235968A (zh) 取代的三环化合物
CN1310911C (zh) 作为脑缺血性疾病和cns疾病治疗剂的哌嗪苯并噻唑
CN1897941A (zh) 趋化因子受体活性的烷基氨基、芳基氨基以及氨磺酰基环戊基酰胺调节剂
CN1017901B (zh) 抗精神病药稠环吡啶基哌嗪衍生物的制备方法
CN1179962C (zh) 氮杂吲哚嗪酮衍生物和以其为有效成分的脑功能改善剂
CN1245169A (zh) 新的硝酮化合物,其制备方法以及含有它们的药物组合物
CN1202109A (zh) 红藻氨酸神经细胞毒性抑制剂及吡啶并噻嗪衍生物
KR100582696B1 (ko) 벤조티아졸
CN1665506A (zh) 作为ccr－3受体拮抗剂ⅸ的2,5－取代的嘧啶衍生物
CN1791600A (zh) 用作腺苷受体的配体的苯并噻唑衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication